Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada

Journal of the American Society of Nephrology

Volumn 11, Issue 5, 2000, Pages 917-922

  Rabbat, Christian G ^a   Thorpe, Kevin E ^b   Russell, J David ^a   Churchill, David N ^a,b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CADAVER KIDNEY; CANADA; DIALYSIS; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL;

EID: 0034011586     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Vollmer WM, Wahl PW, Blagg CR: Survival with dialysis and transplantation in patients with end-stage renal disease. N Engl J Med 308: 1553-1558, 1983
2. Krakauer H, Grauman JS, McMullan MR, Creede CC: The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation. N Engl J Med 308: 1558-1563, 1983
3. Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE: Prognostically controlled comparison of dialysis and renal transplantation. Kidney Int 26: 44-51, 1984
4. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K: Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients. JAMA 270: 1339-1343, 1993
5. Marcelli D, Stannard D, Conte F, Held PJ, Locatelli F, Port FK: ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int 50: 1013-1018, 1996
6. Churchill DN, Taylor DW, Keshaviah PR, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198-207, 1996
7. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ: Impact of renal cadaveric transplantation on survival in end-stage renal failure: Evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 9: 2135-2141, 1998
8. Keown P, for the Tricontinental Mycophenolate Mofetil Renal Transplant Study Group: A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 61: 1029-1037, 1996
9. Cox D: Regression models and life tables. J R Stat Soc 34: 187-201, 1972
10. Cox DR, Oakes D: Analysis of Survival Data, London, Chapman and Hall, 1984, pp137-138
11. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis 15: 451-457, 1990
12. Churchill DN, Thorpe KE, Vonesh EF, Keshaviah PR: Lower probability of patient survival with continuous peritoneal dialysis in the United States compared with Canada. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 8: 965-971, 1997
13. Silins J, Fortier L, Mao Y, Posen G, Ugnat AM, Brancker A, Gaudette L, Wigle D: Mortality rates among patients with end-stage renal disease in Canada, 1981-86. Can Med Assoc J 141: 677-682, 1989
14. United Network of Organ Sharing: 1993 Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network - Transplant Data: 1988-1991, UNOS, Richmond, VA, and the Division of Organ Transplantation, Bureau of Health Resources Development, Health Resources and Services Administration, U.S. Department of Health and Human Services, Bethesda, MD
15. Weinrauch LA, D'Elia JA, Monaco AP, Gleason RE, Welty F, Nishan PC, Nesto RW: Preoperative evaluation for diabetic renal transplantation: Impact of clinical, laboratory, and echocardiographic parameters on patient and allograft survival. Am J Med 93: 19-28, 1992
16. Cosio FG, Alamir A, Yim S, Pesavento TE. Falkenhain ME, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Patient survival after renal transplantation. I. The impact of dialysis pre-transplant. Kidney Int 53: 767-772, 1998
17. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49: 88-96, 1996
18. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21: 113-118, 1993
19. Garcia-Garcia G, Deddens JA, D'Achiardi-Rey R, First MR, Samuels SJ, Kant S, Pollak VE: Results of treatment in patients with end-stage renal disease: A multivariate analysis of risk factors and survival in 341 successive patients. Am J Kidney Dis 5: 10-18, 1985
20. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Patient survival for wait-listed (WL) dialysis versus cadaveric renal transplant (TX) patients in the US [Abstract]. J Am Soc Nephrol 8: 708A, 1997
21. Bloembergen WE, Mauger EA, Wolfe RA, Port FK: Association of gender and access to cadaveric renal transplantation. Am J Kidney Dis 30: 733-738, 1997